Replies to post #15370 on Biostax Corp (BTAX)

[resx18]

Huge news IMO Phase 2 study to evaluate the safety and efficacy of CYTO-201 as a treatment to slow or halt the progression of the SARS-CoV-2 infection from mild/moderate (stage 1-2A) to severe (stage 2B-3).

[noreen]

FINRA won’t process it because of Iliad Research and Trading. They can buy him out if need be, I would imagine.